Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity

被引:5
作者
Do, JS
Choi, YH
Shin, SH
Yi, HK
Hwang, PH
Nam, SY [1 ]
机构
[1] Jeonju Univ, Sch Sci & Technol, Dept Biol Sci, Jeonju 560759, South Korea
[2] Presbyterian Med Ctr, Christian Med Res Ctr, Jeonju 560750, South Korea
[3] Jeonbuk Natl Univ, Sch Med, Dept Pediat, Jeonju 560712, South Korea
基金
新加坡国家研究基金会;
关键词
CD8; T cells; Tcl/Tc2; cells; memory cells; anti-tumor activity;
D O I
10.1016/j.imlet.2004.06.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic CD8(+) T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8+ memory T cells were obtained from mice given with CT26-IL 12 and tumor-specific Tc1 and Tc2 cells were induced by in vitro primary stimulation (1degrees). In vivo anti-tumor immunity and in vitro cytotoxicity of 1degrees Tc2 memory effector cells were highly protective comparably to 1degrees Tc1, but they secreted high level of IFNgamma as well as IL 4 and IL 5. Moreover, memory cells obtained again from tumor-protected mice by either 1degrees Tc1 or Tc2 transfer showed indistinguishable, Tc1-like, cytokine profiles. These results strongly suggest that 1degrees Tc2 cells are insufficiently polarized. Tc2 memory effector cells were therefore examined for their transitional anti-tumor activity during consecutive stimulation until Th2 commitment. Secondary stimulation (2degrees) markedly reduced secretion of IFNgamma (by 94%) and in vivo tumor protection (by 83%). Tertiary (3degrees) and further stimulation completely abrogated both of tumor protective activity and IFNgamma secretion of Tc2 cells. This progressive loss of activity following repeated stimulation was accompanied by a reduction of in vitro cytotoxicity to CT26 tumor cells. In addition, when 1degrees Tc2 cells were trans-differentiated to Tc1 during secondary stimulation, 2 of 6 cultures recovered tumor protective activity concomitantly with IFNgamma secretion, indicating that repeated stimulation does not deteriorate tumor protective activity of 2degrees Tc2 cells. Collectively, these data demonstrate that highly committed Tc2 cells are ineffective in tumor protection. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 45 条
[1]  
Aruga A, 1997, J IMMUNOL, V159, P664
[2]   INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR HAVE A ROLE IN TUMOR REGRESSIONS MEDIATED BY MURINE CD8+ TUMOR-INFILTRATING LYMPHOCYTES [J].
BARTH, RJ ;
MULE, JJ ;
SPIESS, PJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :647-658
[3]   ROLE OF INTERFERON-GAMMA IN MEDIATING THE ANTITUMOR EFFICACY OF INTERLEUKIN-12 [J].
BRUNDA, MJ ;
LUISTRO, L ;
HENDRZAK, JA ;
FOUNTOULAKIS, M ;
GAROTTA, G ;
GATELY, MK .
JOURNAL OF IMMUNOTHERAPY, 1995, 17 (02) :71-77
[4]  
CARTER LL, 1995, J IMMUNOL, V155, P1028
[5]  
Cerwenka A, 1998, J IMMUNOL, V161, P97
[6]   GENERATION OF POLARIZED ANTIGEN-SPECIFIC CD8 EFFECTOR POPULATIONS - RECIPROCAL ACTION OF INTERLEUKIN (IL)-4 AND IL-12 IN PROMOTING TYPE-2 VERSUS TYPE-1 CYTOKINE PROFILES [J].
CROFT, M ;
CARTER, L ;
SWAIN, SL ;
DUTTON, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1715-1728
[7]  
CRONIN DC, 1995, J IMMUNOL, V154, P3118
[8]   Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma [J].
Devaraj, K ;
Gillison, ML ;
Wu, TC .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2003, 14 (05) :345-362
[9]  
Dobrzanski MJ, 1999, J IMMUNOL, V162, P6671
[10]   Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection [J].
Dobrzanski, MJ ;
Reome, JB ;
Dutton, RW .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :424-434